UK Sanders-Brown Center on Aging Facilitates First Participant in Worldwide Drug Study
LEXINGTON, Ky. (July 17, 2020) — Researchers at the University of Kentucky Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study. This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping this study finds that BAN2401 does just that and will ultimately help prevent Alzheimer’s disease.
Stakeholder Advisory Board Member Dr. Beverly May Featured in NIEHS Grantee Highlights
Lexington, Ky. (July 1, 2020) - Beverly May, Dr.P.H., strives to empower rural communities to address the environmental issues that concern their health. As a family nurse practitioner in Appalachian Kentucky, May witnessed firsthand the environmental health effects caused by coal mining and natural gas drilling in the region.
Click here to read the full article on the NIEHS Partnerships for Environmental Public Health website.
Dr. Sarah Tully Marks Recaps Her Year as the Bell Addiction Medicine Scholar
UK Professor Emeritus Chosen to Lead United States Pharmacopeial Convention
LEXINGTON, Ky. (July 14, 2020) — Dennis E. Doherty, MD, professor emeritus of medicine at the University of Kentucky College of Medicine, has recently been named president of one of the world’s largest networks of global experts in science and health.
UK Study Provides New Insight on Colorectal Cancer Growth
LEXINGTON, Ky. (July 14, 2020) — A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase (SMS) to facilitate colorectal cancer growth.
SMS is an enzyme that produces spermine from spermidine, which has been shown to be important for cell growth. However, excessive accumulation of spermidine can have harmful effects on cell viability. How cancer cells maintain a relatively high level of spermidine but below the toxic threshold to facilitate tumor growth is not well understood.
UK Neurologists Working to Ensure Equity, Diversity and Inclusion
LEXINGTON, Ky. (July 14, 2020) - A time for action.
New Manuscript Published in JQPS
Drs. Li and Williams, in collaboration with physicians and faculty from the Department of Communication at the University of Kentucky, published findings from a study on the Interprofessional Teamwork Innovation Model in the Joint Commission Journal on Quality and Patient Safety.
Recent Faculty Publication: "Inhibition of Angiotensin II Dependent AT1a Receptor Stimulation Attenuates Thoracic Aortic Pathology in Fibrillin-1C1041G/+ Mice."
Dr. Jian Fu Appointed to NIH Innate Immunity & Inflammation Study Section
Congratulations to Dr. Alexandra Arenas on a Successful Defense!
